Transarterial Chemoembolization Market: How Is TACE Technology...

added blog Health

2026-04-17 10:22:27 -

Transarterial Chemoembolization Market: How Is TACE Technology Being Applied Beyond HCC?

TACE for non-HCC liver tumors and beyond — the expanding applications of transarterial chemoembolization for colorectal cancer liver metastases (DEBIRI-TACE), neuroendocrine tumor liver metastases, cholangiocarcinoma, and other hepatic malignancies — represents an important market expansion beyond the primary HCC indication, with the Transarterial Chemoembolization Market reflecting...

0 Comments 0 Shares 75 Views 0 Reviews